Morphometry of BrdU+ cells in 2N and Ts65Dn mice
Neurogenesis in the mammalian adult brain is a well established phenomenon (for the recent reviews see Carpentier & Palmer, 2009; Kaneko & Sawamoto, 2009; Rodriguez & Verkhratsky, 2011) that is important in both young and aging brain (Galvan & Jin, 2007; Rao et al., 2006). The subventricular zone, subgranular layer of the dentate gyrus (DG), and cortex are the main sites of adult neurogenesis (Gould et al., 1999; Luskin & Boone, 1994; Palmer et al., 2000; Seki et al., 2007; Yoneyama et al., 2011). Newly-born neurons during adult neurogenesis have the ability to integrate into previously established neuronal networks (Kee et al., 2007; Markakis & Gage, 1999; Sandoval et al., 2011). Alteration of neurogenesis under different experimental and pathological conditions has been described to a great extent (Rodriguez & Verkhratsky, 2011; Sandoval et al., 2011; Winner et al., 2011; Yoneyama et al., 2011; Yu et al., 2009). Significant decreases of neurogenesis have been found in neurodevelopmental (Contestabile et al., 2007; Guidi et al., 2008, 2010) and in neurodegenerative diseases (Rodriguez & Verkhratsky, 2011). Numerous studies provide evidence that a lack of neurogenesis significantly diminishes plasticity in the adult brain and interferes with learning and memory (reviewed in Koehl & Abrous, 2011; Mongiat & Schinder, 2011). Different mechanisms have been proposed to regulate neurogenesis in the adult brain, including brain injury (Kernie & Parent, 2010; Moriyama et al., 2011), ischemia (Kernie & Parent, 2010; Kreuzberg et al., 2010), and inflammation (Voloboueva et al., 2010).
One of the least studied factors that affects neurogenesis are chromosomal aberrations. Down syndrome (DS) results from the extra copy of chromosome 21 occurring with a prevalence of 1 in 733 live births (Canfield et al., 2006). Subjects with DS show developmental regression, diminished cognitive ability, and autonomic dysfunction (Antonarakis & Epstein, 2006; Chapman & Hesketh, 2000). The DS brain is severely affected showing a reduction in both overall size and of particular areas (frontal cortex, hippocampus, cerebellum, and brainstem) due to a reduced number of neurons (Aylward et al., 1997, 1999; Kesslak et al., 1994; Pinter et al., 2001; Raz et al., 1995; Wisniewski et al., 1984).
1.1. Neurogenesis in subjects with DS
Very little data is available describing neurognesis in subjects with DS. In hippocampal DG and neocortex of fetuses with DS the number of proliferating cells was found to be significantly reduced (Contestabile et al., 2007). These reductions were mainly due to a reduced number of cycling cells in S phase (Contestabile et al., 2007). Both a reduction in neurogenesis and significantly higher incidence of apoptotic cell death in the hippocampal region of fetuses with DS has been noted (Guidi et al., 2008). Also, trisomy 21 significantly modify cell phenotypes producing higher numbers of cycling cells going to a glial phenotype and less cells expressing neuronal markers (Guidi et al., 2008). Detailed analysis of the consequences of both reduced neurogenesis and increased apoptosis in fetuses with DS, revealed a severe reduction in the volume and cell number of investigated brain areas (Guidi et al., 2008). More recently, significant neurogenesis impairments were also revealed in the cerebellum of fetuses with DS (Guidi et al., 2010). However, apoptotic cell death was similar in the cerebellum in fetuses with DS vs. controls (Guidi et al., 2010). The differences between the levels of apoptosis in hippocampus vs. cerebellum in fetuses with DS points to different mechanisms for the reduced cell number in hippocampus and cerebellum in DS. For the hippocampus, a reduction of neurogenesis, increased apoptosis and changing cell phenotypes in favor of glia may underlie reduced cell number in fetuses with DS. As for the cerebellum, only a reduction in neurogenesis may be the main factor in decreased cerebellar volume in fetuses with DS.
1.2. Neurogenesis in mouse models of DS
Taking to account that this subject is very important for the neurobiology of DS, only a few papers addressed neurogenesis in mouse models of DS (Bianchi et al., 2010; Chakrabarti et al., 2007; Clark et al., 2006; Contestabile et al., 2007; Lorenzi & Reeves, 2006; Rueda et al., 2005). It was noted that in prenatal and newborn Ts65Dn mice neurogenesis was significantly reduced (Chakrabarti et al., 2007; Contestabile et al., 2007; Lorenzi & Reeves, 2006). At postnatal day 2 cell proliferation in Ts65Dn mice, assessed 2 hours after single injection of bromodeoxyuridine (BrdU) was significantly reduced (Contestabile et al., 2007); similar results were revealed at postnatal day 15 (Bianchi et al., 2010). However in young adult Ts65Dn mice the results are conflicting (Clark et al., 2006; Rueda et al., 2005). Similar procedures in young (3-5 months) Ts65Dn mice shows no difference in hippocampal cell proliferation and survival (Rueda et al., 2005). However, in aged (13-15 months) Ts65Dn mice, cell proliferation in the hippocampus (Rueda et al., 2005) and in the subventricular zone (Bianchi et al., 2010) were significantly reduced. Finally, Clark et al. (2006) found a difference in DG neurogenesis in young (2-5 months) Ts65Dn mice.
It seems that genetic dissections of mouse partial trisomy 16 (Ts65Dn model) did not restore reduced neurogenesis. Indeed, Ts1Cje and Ts2Cje mouse models of DS showed a similar degree of impairment in adult neurogenesis (Hewitt et al., 2010; Ishihara et al., 2010).
To solve these conflicting results in DS mouse models a recent study was initiated to examine young adult neurogenesis, and we also expanded this study to include DG, cortex and corpus callosum (CC) at three different levels. We chose to investigate whether or not trisomy has any affect on neurogenesis in Ts65Dn mice. To carry out this work we injected BrdU in 2N and Ts65Dn mice. Combining BrdU immunoreactivity and high resolution confocal microscopy, we examined the number of BrdU-positive (BrdU+) neurons in DG, cortex and CC at three different levels: rostral, middle and caudal. Comparing 2N and Ts65Dn mice, we discovered significant decreases in the density of BrdU+ cells in trisomic mice in the cortex and DG. We found that the number of cells per cluster was significantly reduced in both the rostral and the caudal parts of DG in the Ts65Dn vs. 2N. This change resulted in reduced cell density in the caudal DG, while the density of clusters was not altered. Our findings are evidence for decreased neurogenesis in young adult cortex and DG of Ts65Dn mice and indicate neurogenesis as a potential target for pharmacological intervention to avert neuronal plasticity in individuals with DS.
2. Materials and methods
All experiments were conducted in accordance with the National Institutes of Health guidelines for the care and use of animals and with an approved animal protocol from the Stanford University Institutional Animal Care and Use Committee. All efforts were made to minimize animal stress and discomfort.
2.1. Mice husbandry
Details of maintenance and using Ts65Dn mouse colony were described previously (Belichenko et al., 2004). The Ts65Dn mouse colony was maintained for more than 10 generations by crossing B6EiC3Sn-Ts(1716)65Dn females (Jackson Laboratory, Bar Harbor, ME) with B6EiC3Sn F1/J A/a males (Jackson Laboratory). This breeding scheme was used because trisomic mice breed very poorly or not at all when inbred; the B6C3 background has been the most successful. To distinguish 2N from Ts65Dn mice, genomic DNA was extracted from tail samples. A quantitative PCR protocol (provided by The Jackson laboratory) was used to measure Mx1 gene expression, which is present in three copies in Ts65Dn. Each mouse was genotyped twice. Male littermates mice were used in all studies at ages 2-3 months.
2.2. BrdU injections and immunofluorescent staining
In the beginning of experiment we weighed mice. Each animal was injected once a day for 6 consecutive days with 5-bromo-2′-deoxyuridine (BrdU, 10 mg/ml in saline, i.p.) (Cat. # B9285, Sigma-Aldrich Corp., St. Louis, MO, USA) to a final dose of 50 mg/kg body weight. Twenty four hours after the last injection, animals were deeply anesthetized with sodium pentobarbital (200 mg/kg i.p.) (Abbott Laboratories, North Chicago, IL, USA), again weighed, and transcardially perfused for 1 minute with 0.9% sodium chloride (10 ml) and then for 20 minutes with 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS), pH 7.4 (200 ml). After perfusion, the brain was immediately removed and postfixed for another 24 hours. The weight of the entire brain (including the olfactory bulbs, cerebellum, and brainstem along with the cervical spinal cord through C1–C2) was recorded. The brain was then sectioned coronally at 100-μm with a Vibratome (series 1000, TPI Inc., St. Louis, MO, USA), and sections were placed in 0.9% NaCl solution. Immunofluorescence method with anti-BrdU antibody was used to reveal BrdU+ cells as follows. Free-floating sections were rinsed twice in saline (0.9 % NaCl) for 10 min at RT, and then pretreated with 1M HCl for 30 minutes at 37ºC. Sections were neutralized by rinsing 3 times in PBS and then pre-incubated in a solution of 0.1 M PBS containing 5% non-fat milk and 0.3% Triton-X 100 (PBS+), for 1 hour at room temperature. Then sections were incubated overnight at 4oC with primary rat anti-BrdU antibody (Cat. #MCA2060, Serotec, Raleigh, NC, USA) at a dilution 1:100 in PBS+. Sections were rinsed in PBS (20 minutes, three changes) and incubated for 1 hour at room temperature with biotinylated donkey anti-rat IgG (1:200; Jackson ImmunoResearch Labs, West Grove, PA). After being rinsed with PBS (20 minutes, three changes), sections were incubated with FITC-conjugated streptavidin (1:500; Jackson ImmunoResearch Labs, West Grove, PA) for 1 hour at room temperature. Following further careful rinsing, the sections were mounted on microscope glass slides and coverslipped with 90% glycerol in PB.
2.3. Confocal microscopy imaging, cell quantification, cluster and statistical analyses
To study cell proliferation and clustering in 2N and Ts65Dn mice we used confocal microscopy imaging of BrdU+ cells in the cortex, hippocampus and CC. Confocal imaging of brain slices labeled with one fluorophores was performed as previously described (Belichenko et al., 2004). In brief, slices with BrdU+ cells were examined and scanned in a Radiance 2000 confocal microscope (BioRad, Hertfordshire, United Kingdom) attached to a Nikon Eclipse E800 fluorescence microscope. LaserSharp software (Bio Rad) was used to establish optimal conditions for collecting images. The laser was an argon/krypton mixed gas laser with exciting wavelengths for FITC (488 λ). The emission was registered with HQ515/30 “green” filter. Sections with FITC staining of BrdU immunoreactivity were studied under the following optimal conditions: the lens was a x10 objective (Nikon; Plan Fluor x10/0.30); laser power was 10%; the zoom factor was 1; scan speed was 500 lines per second; each optical section was the result of 3 scans followed by Kalman filtering; the size of the image was 512 x 512 pixels (i.e., 1208 x 1208 µm).
LazerPix software (Bio Rad) analysis of confocal images was used to measure the area or length of investigated brain structures, and for quantitative analysis of BrdU+ cells. Three slices per mouse (500 μm apart) were used. The location of each coronal section was designated based on its relative position to bregma in mm (Hof et al., 2000). Rostral section was corresponded to bregma -1.60 mm level, middle section – to bregma -2.10 mm level, and caudal section to bregma -2.60 mm level. Entire DG at these three different locations was imaged. CC was imaged from midline and then for 1200 μm to the left or right extension at the same three different locations. Based on mouse brain atlas (Hof et al., 2000), cortex were correspondent to motor cortex at rostral and middle sections and to visual cortex at caudal section). Images from the both the left and right side for each mouse brain were analyzed. To count number of BrdU+ cells, we first outlined the area of interest and measure area or length (in a case of DG). Next, for each image, the intensity thresholds were estimated by analyzing the distribution of pixel intensities in the image areas that did not contain immunoreactivity. This value, the background threshold, was then subtracted and number of BrdU+ cells was counted. In addition each BrdU+ cells were traced manually and their XY coordinates were exported to Excel. The number of BrdU+ cell in each hemisphere was expressed for DG as per 100-μm length of neurogenic subgranule zone, and for cortex and CC as per 1 mm2. We also counted the occurrence of BrdU+ cell clusters. To quantify the number of clusters we used previously established criteria (Palmer et al., 2000), where cluster was defined as a contiguous group of cells separated by less than 25 μm. Special macro was design in Excel program for cluster counting. For every section, X and Y coordinates of individual BrdU+ cell were recorded using LaserPix software (BioRad). Distance between all pairs of the BrdU+ cells within one section were calculated using an Excel Microsoft macro, and the cells with distances < 25 μm were regarded as belonging to a cluster. All analyses were performed by the same investigator blinded to mice genotype.
Digital images were imported, enhanced for brightness and contrast, assembled and labeled in Adobe Photoshop CS2 9.0.2, and archived. Figures were printed with a Phaser 7300 color printer (Tektronix by Xerox, Norwalk, CT).
The data for body and brain weights, total number of BrdU+ cells, their coordinates and cluster evaluations were exported to Excel (Microsoft, Redmond, WA) and statistical comparisons were performed using two-way analysis of variance (ANOVA) and for two samples using two-tailed Student’s t-tests. All results are expressed as mean ± SEM, and P values < 0.05 were considered to be significant.
3.1. Body and brain weights
The body weight of 2N and Ts65Dn mice at 2-3 months was similar (2N: 31.1 ± 1.6 g, n = 6; Ts65Dn = 26.7 ± 2.3 g, n = 5; P = 0.14). The brain weight was also unchanged (2N: 0.43 ± 0.01 g, n = 6; Ts65Dn = 0.43 ± 0.01 g, n = 5; P =0.60). Of note, there was no effect of the BrdU injection on changes in body weight during 6 day injections since no significant differences were found between 2N and Ts65Dn mice (2N: -0.60 ± 0.29 g, n = 6; Ts65Dn = -0.20 ± 0.51 g, n = 5; P =0.49). These mice also showed no aversive or any other neurological symptoms during injection.
3.2. Changes in BrdU+ cells number and in cell cluster density in Ts65Dn mice
We examined the density of BrdU+ cells in DG of hippocampus, cortex and CC in 2N and Ts65Dn male mice (Table 1, Figs. 1, 2). The BrdU+ cells were bright fluorescent, allowing for a detailed quantitative analysis by confocal microscopy (Figs. 1a, 2a). For this analysis, the number of BrdU+ cells per 100 μm length of subgranule zone for DG or per 1 mm2 area of cortex or CC was counted to define cell density (Table 1). In addition we measured the number of cell cluster, the number of BrdU+ cells per cluster and the frequency distribution of BrdU+ cells per cluster (Table 1; Figs. 1 d, e; 2 d,e).
Comparing BrdU+ cell densities in 2N and Ts65Dn mice, there was a statistically significant decrease in the caudal part of DG (by 27%) and in the rostral part of motor cortex (by 36%; P < 0. 01; Table 1). Interestingly, BrdU+ neurons in the inferior blade were on average 30% fewer than in the superior blade for 2N, and 23% fewer for Ts65Dn mice (P < 0.01; Table 1). BrdU+ cell density were similar for CC in 2N and Ts65Dn mice, and 33% more in caudal then rostral CC for 2N mice (P < 0.01; Table 1).
Comparing BrdU+ cell cluster densities in 2N and Ts65Dn mice, there was a statistically significant decrease in the rostral part of motor cortex (by 29%; P < 0. 01; Table 1). In the inferior blade there were on average 9% fewer than in superior blade for 2N, and 25% fewer for Ts65Dn mice (P < 0.05; Table 1). Interestingly, in the DG the BrdU+ cell cluster density was not different in 2N and Ts65Dn mice (Table 1).
We next quantified the number of cells per cluster (Table 1). As compared to 2N mice, significantly lower numbers of BrdU+ cells per cluster were present in rostral (mainly due to superior blade, P < 0.003; Table 1) and in the caudal part of DG in Ts65Dn mice (P = 0.03; Table 1), and in the rostral part of motor cortex in Ts65Dn mice (P < 0.01; Table 1). Comparing the superior and inferior blades in 2N mice, numbers of cells per cluster were ~1.5 times higher in the rostral and middle parts of the superior blade of the DG in 2N mice (P < 0.02; Table 1).
In conclusion, significant differences in the number of BrdU+ cells, cell cluster densities, and in number of BrdU+ cells per cluster were evident for Ts65Dn mice as compared to their 2N cohorts. These findings are evidence for reduced neurogenesis in both DG and cortex due to mouse chromosome 16 trisomy.
|cell density||cluster density||# cells per cluster|
|Total||3.06 ± 0.27||2.87 ± 0.25||1.01 ± 0.08||1.22 ± 0.09||3.05 ± 0.22||2.39 ± 0.16a|
|Superior blade||3.61 ± 0.29||3.13 ± 0.36||1.02 ± 0.11||1.25 ± 0.09||3.69 ± 0.29||2.47 ± 0.21a|
|Inferior blade||2.55 ± 0.25b||2.55 ± 0.25||0.99 ± 0.08||1.19 ± 0.13||2.65 ± 0.29b||2.42 ± 0.37|
|Total||2.88 ± 0.17||2.77 ± 0.15||1.21 ± 0.05||1.17 ± 0.08||2.56 ± 0.20||2.52 ± 0.12|
|Superior blade||3.33 ± 0.21||3.01 ± 0.17||1.23 ± 0.05||1.24 ± 0.09||3.01 ± 0.26||2.66 ± 0.12|
|Inferior blade||2.28 ± 0.18b||2.46 ± 0.20c||1.19 ± 0.08||1.08 ± 0.14||1.96 ± 0.17b||2.51 ± 0.34|
|Total||2.73 ± 0.19||2.00 ± 0.08a||1.13 ± 0.04||1.10 ± 0.08||2.59 ± 0.31||2.01 ± 0.12a|
|Superior blade||3.09 ± 0.27||2.31 ± 0.12a||1.21 ± 0.07||1.22 ± 0.10||2.84 ± 0.27||1.69 ± 0.16a|
|Inferior blade||2.20 ± 0.19b||1.55 ± 0.15a,c||1.10 ± 0.06b||0.92 ± 0.07c||2.21 ± 0.22||1.69 ± 0.16a|
|Rostral||21.1 ± 2.2||14.6 ± 1.4a||14.4 ± 1.4||10.2 ± 1.2a||1.46 ± 0.04||1.24 ± 0.05a|
|Middle||22.3 ± 2.9||19.5 ± 1.8||15.9 ± 1.5||14.9 ± 1.7||1.25 ± 0.03||1.22 ± 0.02|
|Caudal||25.0 ± 2.5||19.7 ± 2.7||14.9 ± 1.7||13.9 ± 1.7||1.30 ± 0.03||1.26 ± 0.04|
|Rostral||74.7 ± 11.3||87.2 ± 12.6||56.7 ± 3.1||53.0 ± 5.6||1.15 ± 0.05||1.16 ± 0.03|
|Middle||96.1 ± 15.8||77.3 ± 13.4||64.1 ± 7.2||62.6 ± 7.6||1.28 ± 0.07||1.22 ± 0.03|
|Caudal||111.2 ± 11.8b||105.1 ± 16.1||73.8 ± 7.3||73.2 ± 9.4||1.36 ± 0.06||1.32 ± 0.04|
|The number of mice used was as follows: 2N/Ts65Dn = 6/5.|
|Each value represents the mean ± SEM.|
|BrdU+ cells and clusters densities are expressed as: for FD per 100 μm length of subgranule zone, for cortex and CC per 1 mm2.|
|a, P < 0.05, significantly different from 2N mice.|
|b, P < 0.05, significantly different between 2N mice.|
|c, P < 0.05, significantly different between Ts65Dn mice.|
Numerous studies have shown that adult neurogenesis is affected by various neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s diseases (reviewed in Curtis et al., 2011; Kaneko & Sawamoto, 2009; Rodriguez & Verkhratsky, 2011; Winner et al., 2011). Alteration of neurogenesis in neurodevelopmental disorders were studied to a lesser extent in DS (Contestabile et al., 2007; Guidi et al., 2008, 2010), autism spectrum disorders (Greco et al., 2011; Wegiel et al., 2010), including Rett syndrome (Ronnett et al., 2003).
Studies to understand the neurobiology of DS have benefited from the ability to examine mouse models of the disorder (Belichenko et al., 2004; 2007; 2009; Kleschevnikov et al., 2004; Popov et al., 2011). Previous studies demonstrated that trisomy in Ts65Dn mouse model of DS resulted in alteration of hippocampal long-term potentiation (LTP) (Kleschevnikov et al., 2004; Siarey et al., 1997). Significant alteration of neurogenesis could be one of the contributing factors to diminished plasticity in DS. Interestingly, studies involving mice to different enrichments or pharmacotherapies enhanced both neurogenesis and learning (Deng et al., 2010; Mongiat & Schinder, 2011; Saxe et al., 2006; Shors et al., 2002; Singer at al., 2011), including Ts65Dn mice (Bianchi et al., 2010). Moreover, manipulations that stimulate adult neurogenesis in mice also increase LTP (van Praag et al., 1999).
Our study in the Ts65Dn mouse model of DS presents novel evidence of altered neurogenesis in adult young mice (2-3 months of age). Significant increases in the number of clusters containing single BrdU+ cells in Ts65Dn mice point to severely affected cell proliferation. Our present data are in agreement with previous data (Clark et al., 2006) and conflicting with Rueda et al. (2005) data on young adult Ts65Dn mice. The discrepancy with the Rueda et al. (2005) results likely result from several factors including the different gender of mice (we used only male mice and no gender of studied mice were mentioned in Rueda et al., 2005), the different brain areas investigated (we studied rostral, middle, and caudal parts of hippocampus, cortex and CC separately, while in Rueda et al. (2005) the entire hippocampus was studied). The BrdU injection protocol was also different. We used standard a procedure with BrdU injection during 6 days, while Rueda et al., (2005) used a 12 days injection approach.
The majority of BrdU+ cells in adult brain during the proliferation phase formed clusters (Palmer et al., 2000; Seki et al., 2007). Data on neurogenesis in adult rat hippocampus suggests that newly-born cells appeared to stay in clusters for a few days and then migrate from clusters (Seki et al., 2007). Currently, little is known about the molecular mechanisms of cluster formation. Previous reports suggested that cell clustering supports intercellular contacts and/or signals that encourage neurogenesis (Seki et al., 2007). It is possible that the initial formation of a cluster is triggered by a certain factor, which is not affected in Ts65Dn mice. Thus, we have similar cluster density in Ts65Dn vs. 2N mice. The ‘just-divided’ cells could be divided further, thus resulting in a cluster (Seki et al., 2007). However, this could be only accomplished when the cell is going through all cycles. Indeed, as was shown previously (Contestabile et al., 2008) that the dividing in Ts65Dn cells are ‘stuck’ in S phase, thus decreasing the probability of cell cycle re-entry. This delay could suspend the second and the following divisions, thus resulting in a reduced number of the newly-born cells per cluster. Interestingly, we observed that the number of cells per cluster was reduced only in the rostral and caudal, but not in the middle part of the Ts65Dn hippocampus. The exact nature of this phenomenon is not clear yet, but may result from differences in the structure and function of hippocampus along the rostro-caudal axis. Indeed, neuronal network architecture is different in hippocampus (Witter et al., 2000).
Reduction in the number of cells per cluster leads to a reduction of total number of newly-born neurons in the Ts65Dn hippocampus. It was shown previously that LTP in the DG depends strongly on neurogenesis, and that a blockade of neurogenesis results in reduced synaptic plasticity (Snyder et al., 2001). Because we observed that LTP in the DG of Ts65Dn mice is significantly diminished (Kleschevnikov et al., 2004), it is tempting to assume that reduced neurogenesis is one of the factors contributing to this abnormality. It is clear that alteration in prenatal growth of the cortex and hippocampus in trisomic mice is due to a longer cell cycle and reduced neurogenesis (Chakrabarti et al., 2007; Contestabile et al., 2007).
We further propose that alteration of neurogenesis may also affect the balance between excitation and inhibition. Indeed, the putative young neurons are completely unaffected by GABA(A) inhibition (Wang et al., 2000). Reduced number of such disinhibited neurons in DG of Ts65Dn mice could thus result in elevation of the overall efficiency of the inhibitory system (Belichenko et al., 2009; Kleschevnikov et al., 2004). The excitatory/inhibitory neuron ratio could be affected also in other bran regions. The new granule cells of the DG, olfactory bulb, and cerebellum and the new cells in cortex are constantly produced during adult neurogenesis. However, there are many differences between these cells. For example, in the olfactory bulb and neocortex the newly-born cells are mainly inhibitory (GABAergic) (reviewed in Cameron & Dayer, 2008). Reduced neurogenesis in these regions could result in relative disinhibition and, thus, could be regarded as a factor contributing to epilepsy in DS (Goldberg-Stern et al., 2001; Menendez, 2005; Pueschel et al., 1991). In contrast, DG and cerebellar granule cells are excitatory (glutamatergic). However, this question needs to be studied in greater detail. The influence of chromosomal aberration on the transition from proliferating stage to differentiated stage into either glutamatergic or GABA-ergic neurons should be also studied.
Numerous factors can be implicated in the control of adult neurogenesis, including chromosomal aberrations. Although the exact mechanism(s) of influence of partial or complete trisomy on neurogenesis is not known, we can extract some data from the scattered information. Impaired neurogenesis has been described not only in Ts65Dn (Rueda et al., 2005; Clark et al., 2006; Lorenzi and Reeves, 2006; Constestabile et al., 2007; Chakrabarti et al., 2007; Bianchi et al., 2010) and Ts2Cje (Ishihara et al., 2010) mouse models of DS, but also in TsCje1 mice (Hewitt et al., 2010; Ishihara et al., 2010) with smaller triplicated chromosomal region. Genetic dissection approaches (Ts65Dn vs. Ts1Cje) point out to the same genes in smaller triplicated region, i.e. Itsn1, Dyrk1A, Olig2 may involve in neurogenesis (Hewitt et al., 2010; Ishihara et al., 2010). It has been proposed that overexpressions of Dyrk1A in trisomic segment may be responsible for impaired neurogenesis in Ts65Dn, Ts2Cje, and Ts1Cje mouse models of DS (Canzonetta et al., 2008; Ishihara et al., 2010). These authors also suggest that altered neurogenesis in the Ts1Cje mouse is due to a reduction in neuronal progenitors and neuroblasts rather than neural stem cells (Hewitt et al., 2010). The further identification and characterization of triplicated genes in altered neurogenesis may significantly contribute to understanding the neurobiology of DS and may lead to the development of pharmacotherapy for DS.
Down syndrome (DS) is a neurodevelopmental disorder caused by the triplication of chromosome 21. Few studies have explored neurogenesis in mouse models of DS and these have produced conflicting results on the alteration of neurogenesis. Using confocal microscopy analysis we have examined adult neurogenesis in the hippocampus (dentate gyrus, DG), motor cortex and corpus callosum (CC) of male wild-type (2N) and Ts65Dn mice at age 2-3 months. In Ts65D we found significant decreases in the BrdU+ cells density in DG and motor cortex. BrdU+ cell cluster density were higher in rostral motor cortex in Ts65Dn. Number of BrdU+ cells per cluster were significantly lower in DG and motor cortex of Ts65Dn mice, mainly due to the presence of single cell clusters. Density of BrdU+ cells was significantly lower in the inferior than in the superior blade of DG. Thus, we show for the first time a lower density of BrdU+ cells in Ts65Dn mice. Our findings are evidence on a deficiency of adult neurogenesis in Ts65Dn mouse model of DS. Moreover, we propose a correlation of the present data with our previously published data on alteration of LTP due to excessive inhibition in Ts65Dn mouse model of DS. The new findings can shed light on possible mechanisms underlying the changes in the Ts65Dn neurogenesis, synaptic structure and function that were described previously. Based on our data and recent studies we reasonable suggested that new complex therapies should improve neurogenesis, and as consequence also learning and memory.
We thank Dr. Theo D. Palmer and Dr. William C. Mobley for their critical inputs in the beginning of this work. We also thank Michael Maloney for critically reading the article. This work was supported by the Larry L Hillblom Foundation and by the Down Syndrome Research and Treatment Foundation.